Literature DB >> 30200838

Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.

Aditya N Jha1, Hrishikesh Mishra1, Henu K Verma1, Isha Pandey1, Bhaskar V K S Lakkakula1.   

Abstract

Hemoglobinopathies evolved as a protective mechanism against malaria, which exhibit selective advantage in the heterozygous state. However, in a homozygous recessive condition, it poses a serious socioeconomic burden. Sickle cell anemia is an autosomal recessive hemoglobinopathy associated with erythrocytes sickling, vaso-occlusive crisis (VOC), as well as multi-organ failure and death. The coinheritance of other hemoglobinopathies is known to substantially modulate the clinical manifestation of sickle cell anemia. In the present study, we aimed to analyze the coinheritance of β-thalassemia (β-thal) in Hb S (HBB: c.20A>T) patients. The study includes 918 sickle cell anemia patients from 10 ethnic populations of Chhattisgarh State, India. Complete blood counts (CBCs) and hemoglobin (Hb) high performance liquid chromatography (HPLC) fractionation data were collected from patient record books. We observed Hb S-β-thal in all the analyzed populations. Interestingly, high frequencies of Hb S-β-thal have been observed in Satnami (53.8%), Rawat (47.1%), Gond (35.1%) and Panika (30.6%) populations. Inter-population comparison of hematological parameters [Hb F (p < 0.001), Hb A2 (p < 0.001), Hb (p = 0.03) and red blood cell distribution width (RDW) (p < 0.001)] revealed significant differences. We also observed that mean Hb F levels were significantly higher in Hb S compared to Hb S-β-thal patients in the respective populations. Our study highlights the higher prevalence of β-thal as well as the compound heterozygosity for Hb S and β-thal in various populations of Chhattisgarh State, India.

Entities:  

Keywords:  Chhattisgarh State; Fetal hemoglobin (Hb F); compound heterozygosity; sickle cell anemia; sickle cell disease; β-Thalassemia (β-thal)

Mesh:

Substances:

Year:  2018        PMID: 30200838     DOI: 10.1080/03630269.2018.1483946

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  3 in total

Review 1.  Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy.

Authors:  Henu Kumar Verma; Yashwant Kumar Ratre; L V K S Bhaskar; Raffaella Colombatti
Journal:  Ann Hematol       Date:  2021-01-04       Impact factor: 3.673

2.  Never-homozygous genetic variants in healthy populations are potential recessive disease candidates.

Authors:  Torsten Schmenger; Gaurav D Diwan; Gurdeep Singh; Gordana Apic; Robert B Russell
Journal:  NPJ Genom Med       Date:  2022-09-08       Impact factor: 6.083

3.  β-Thalassemia pathogenic variants in a cohort of children from the East African coast.

Authors:  Alexander W Macharia; George Mochamah; Sophie Uyoga; Carolyne M Ndila; Gideon Nyutu; Metrine Tendwa; Emily Nyatichi; Johnstone Makale; Russell E Ware; Thomas N Williams
Journal:  Mol Genet Genomic Med       Date:  2020-05-11       Impact factor: 2.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.